CollPlant, Stratasys Explore 3D-Printed Breast Implants
CollPlant Biotechnologies and Stratasys Ltd. have initiated a pre-clinical study to develop 3D-printed regenerative breast implants that promote natural tissue growth and biodegrade over time.
CollPlant Biotechnologies and Stratasys Ltd. have initiated a pre-clinical study to develop 3D-printed regenerative breast implants that promote natural tissue growth and biodegrade over time.
The refreshed program introduces a simplified discount structure, real-time program tracking, and new rewards designed to support practice growth.